MedTrace Logo

Pain Control During Braces Removal Using Transcutaneous Electrical Nerve Stimulation and High-Frequency Vibration

NCT07293975 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-04-20

No results posted yet for this study

Summary

This study aims to find the best method to reduce pain during braces removal. We are comparing transcutaneous electrical nerve stimulation (TENS), high-frequency vibration, and a control group with no additional intervention.

People who have completed orthodontic treatment and need their braces removed can take part. Participants will be randomly assigned to one of the three groups. The vibration device will be applied during the braces removal, while TENS will be applied just before the procedure.

Before the procedure, participants' anxiety will be measured using the Modified Dental Anxiety Scale (MDAS). During and after the procedure, pain will be assessed using a Visual Analog Scale (VAS) from 0 to 100, and participants will rate their satisfaction using a Numerical Rating Scale (NRS) from 0 to 10.

The purpose of this research is to help orthodontists identify the method that makes braces removal less uncomfortable, more tolerable, and more satisfying for patients.

Conditions

  • Orthodontic Pain

Interventions

DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS)

TENS is applied immediately before orthodontic bracket removal in a single session to reduce pain and improve patient satisfaction.

DEVICE

High-Frequency Vibration

High-frequency vibration is applied during orthodontic bracket removal in a single session to reduce pain and improve patient satisfaction.

Sponsors & Collaborators

  • University of Baghdad

    lead OTHER

Principal Investigators

  • Ali M. Al-Attar, BDS, MSc, PhD · University of Baghdad - College of Dentistry - Orthodontics

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-06-30
Completion
2026-09-30
FDA Device
Yes

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07293975 on ClinicalTrials.gov